Stay updated on Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added and revision v3.4.2 was removed from the record history. This reflects a version-control update to the study record rather than a change to study content.
    Difference
    0.1%
    Check dated 2026-03-05T19:24:28.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Added revision v3.4.2 and removed revision v3.4.1 in the history.
    Difference
    0.1%
    Check dated 2026-02-12T02:28:49.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The history shows a new revision entry (v3.4.1) was added and the previous revision (v3.4.0) removed from the history; there are no substantive content changes to the study record, To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T00:39:38.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The new screenshot adds a glossary toggle and color-coded change explanations (green for additions, red for deletions) and updates the revision label to v3.4.0, while removing the No FEAR Act data text and its previous revision label.
    Difference
    0.7%
    Check dated 2026-01-28T21:32:04.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page history shows a new revision (v3.3.4) replacing the previous revision (v3.3.3). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:43:48.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.3.3' was added and the 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' items were removed from the footer. These changes are navigation/metadata updates rather than substantive content.
    Difference
    0.1%
    Check dated 2025-12-23T23:15:03.000Z thumbnail image

Stay in the know with updates to Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.